com.insightguru.giraffe.server.utils.PresentationUtil$PresentationTitle@50b81572
This site requires JavaScript to function properly.
For help enabling JavaScript click here.
Here are some sample widgets you could interact with from this dashboard:
(1) Revenues expected to be in line with consensus estimates
Trefis estimates CVS's Q2 2021 revenues to be $70.3 Bil, in line with the consensus estimate of $70.1 Bil
Estimated Revenues - 2021Q2(E)
Trefis Estimates for CVS Health Revenues:
Expected Change (YoY): 7.6%
The chart to the right highlights trends in CVS Health's Revenues over the last four quarters along with our forecast for Q2 2021.
Quarterly Revenue Trend
(2) EPS likely to marginally beat consensus estimates
CVS's Q2 2021 earnings per share (EPS) expected to be $2.09 per Trefis analysis, marginally beating the consensus estimate of $2.06 by 1.5%
Estimated EPS- 2021Q2(E)
Trefis Estimates for CVS Health EPS:
Expected Change (YoY): -7.9%
The chart to the right highlights trends in CVS's EPS over the last four quarters along with our forecast for Q2 2021.
Quarterly EPS Trend
(3) Stock price estimate 12% higher than current market price
Trefis maintains a fair value of $92 for CVS's stock as opposed to the current market price of roughly $82.
CVS Stock Price
The Trefis Price Estimate for CVS Health stock represents the fair value for the company's stock over a one-year horizon.
Details about the chances of a rise in CVS stock in the near term can be found in a separate interactive dashboard.
The chart to the right highlights trends in CVS's stock price at the end of each of the last four quarters as well as the current stock price.
Stock Price (Quarter End)
#1. Estimating CVS Health's Total Revenues:
CVS Health's Revenues have seen a substantial increase of 35.5% from around $228 Bil in FY2018 to $309 Bil in FY2020 and we expect it to increase to $324 Bil in FY2021
Total Revenue
A Separate Interactive Dashboard Analysis On CVS Health's Revenues Details How The Company Makes Money.
Comparing CVS Health's Total Revenues with that of its Peers
CVS Health - Total Revenue
Walgreens Boots Alliance - Total Revenue
#2. Deriving CVS Health's Adjusted Net Income:
CVS Health's Adjusted Net Income has increased from around $7.4 Bil in FY2018 to $9.9 Bil in FY2020 and we expect it to increase to $10.0 Bil in FY2021
This change is likely to be led by higher revenues and weaker margins.
A Separate Interactive Dashboard Analysis On CVS Health's Margins Highlights The Company's Various Expenses Components In Detail.
Adjusted Net Income [AxB]
Adjusted Net Income Margin [A]
Total Revenue [B]
#3. Determining CVS Health's Adjusted EPS:
CVS Health's Adjusted EPS has increased from $7.1 in FY2018 to $7.5 in FY2020 and we expect it to increase to $7.65 in FY2021
The change in EPS can be attributed to an increase in adjusted net income and a lower expected share count due to stock repurchases.
Adjusted EPS [A÷B]
Adjusted Net Income [A]
Shares Outstanding [B]
#4. Estimating CVS Health's Share Price:
Our Price Estimate of $92 For CVS Health's Stock is based on our Detailed Valuation Model, and implies a 12.0x P/E Multiple on expected FY2021 Adjusted EPS of $7.65
Trefis Price Estimate [AxB]
Adjusted EPS [A]
P/E Multiple [B]
Comparing CVS Health's Historical P/E Multiple with that of its Peers
CVS Health P/E Multiple
Walgreens Boots Alliance P/E Multiple